BIOMAT Database Logo BIOMAT Database Logo

Proteoglycan- and fibrin-degrading neutral proteinase activities of Lewis lung carcinoma cells. 1980

X Emonds-Alt, and E Quisquater, and G Vaes

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I

Related Publications

X Emonds-Alt, and E Quisquater, and G Vaes
Cartilage-degrading neutral proteinase secreted by Yoshida sarcoma cells. Purification and properties.
June 1984, The Journal of biological chemistry,
X Emonds-Alt, and E Quisquater, and G Vaes
Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor.
November 1989, Kidney international,
X Emonds-Alt, and E Quisquater, and G Vaes
The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells.
April 1988, The Biochemical journal,
X Emonds-Alt, and E Quisquater, and G Vaes
Phenotypic characteristics of lewis lung carcinoma cells.
October 2002, Bulletin of experimental biology and medicine,
X Emonds-Alt, and E Quisquater, and G Vaes
Antimetastatic potentials of Phyllanthus urinaria L on A549 and Lewis lung carcinoma cells via repression of matrix-degrading proteases.
September 2012, Integrative cancer therapies,
X Emonds-Alt, and E Quisquater, and G Vaes
Decrease of metastatogenic potential by pregraft treatment of Lewis lung carcinoma cells with proteinase and protein kinase affinity labels.
November 1985, Cancer research,
X Emonds-Alt, and E Quisquater, and G Vaes
Partial purification and characterization of a proteoglycan-degrading neutral protease from bovine epiphyseal cartilage.
January 1984, Journal of orthopaedic research : official publication of the Orthopaedic Research Society,
X Emonds-Alt, and E Quisquater, and G Vaes
Metastatic heterogeneity of cells from Lewis lung carcinoma.
November 1983, Cancer research,
X Emonds-Alt, and E Quisquater, and G Vaes
Human rheumatoid arthritic cartilage and its neutral proteoglycan-degrading proteases. The effects of antirheumatic drugs.
April 1985, Arthritis and rheumatism,
X Emonds-Alt, and E Quisquater, and G Vaes
Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
July 1987, Cancer research,
Copied contents to your clipboard!